EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B

Guoqing Liu, Jie Sun iD, Zekun Li iD, Zhenping Chen iD, Wenman Wu, Runhui Wu iD

Blood · 2023

DOI: 10.1182/blood.2022017871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Guoqing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Hemophilia B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia BHumansSerine ProteasesSerineMutationFactor IXSerine Endopeptidases

Substanzen

Serine ProteasesSerineFactor IXSerine Endopeptidases

Autor:innen und Institutionen

  • Hemophilia Comprehensive Care Center, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  • Faculty of Laboratory Medicine, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

ORCID-Profile: Jie Sun, Zekun Li, Zhenping Chen, Runhui Wu

Zitieren

APA

Liu, G., Sun, J., Li, Z., Chen, Z., Wu, W., & Wu, R. (2023). F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B. Blood. https://doi.org/10.1182/blood.2022017871

Vancouver

Liu G, Sun J, Li Z, Chen Z, Wu W, Wu R. F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B. Blood. 2023. doi:10.1182/blood.2022017871

BibTeX
@article{Liu2023,
  author = {Liu, Guoqing and Sun, Jie and Li, Zekun and Chen, Zhenping and Wu, Wenman and Wu, Runhui},
  title = {F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2022017871}
}
Kostenlos starten →